Antibody Therapy for COVID-19: Categories, Pros, and Cons

H Zare Marzouni, M Rahbar, N Seddighi… - Viral …, 2022 - liebertpub.com
COVID-19 is a life-threatening respiratory disease triggered by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2). It has been considered a pandemic viral infection …

[HTML][HTML] Integrated model for COVID-19 diagnosis based on computed tomography artificial intelligence, and clinical features: a multicenter cohort study

Y Kataoka, Y Kimura, T Ikenoue… - Annals of …, 2022 - ncbi.nlm.nih.gov
Background We developed and validated a machine learning diagnostic model for the novel
coronavirus (COVID-19) disease, integrating artificial-intelligence-based computed …

Blood‐derived product therapies for SARS‐CoV‐2 infection and long COVID

J Wu, H Yang, D Yu, X Yang - MedComm, 2023 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is capable of large‐scale
transmission and has caused the coronavirus disease 2019 (COVID‐19) pandemic. Patients …

COVID-19 therapies: do we see substantial progress?

L Matusewicz, M Golec, A Czogalla… - Cellular & Molecular …, 2022 - Springer
The appearance of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its
spread all over the world is the cause of the coronavirus disease 2019 (COVID-19) …

Surgeons' involvement in COVID-19 treatment: a practice by a regional core hospital in Japan to avoid physician burnout

Y Matsui, S Yao, T Kumode, K Tanino, R Mizuno… - BMC Health Services …, 2023 - Springer
Background To prevent task accumulation on certain divisions, our institution developed a
unique system of allocating inpatient treatment of COVID-19 patients to doctors who were …

Use of sotrovimab in vaccinated versus unvaccinated COVID‐19 patients in a resource‐limited emergency department during the omicron surge

RV Nene, MA Santodomingo, B Balog… - Journal of the …, 2023 - Wiley Online Library
Objective The treatment of outpatient COVID‐19 patients at high risk of disease progression
has been challenging, as both the virus and available therapeutics change. Here, we sought …

[HTML][HTML] Inhaled corticosteroids' effect on COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials

Y Badi, M Hammad, AG Tawfik… - Canadian Journal of …, 2023 - ncbi.nlm.nih.gov
Background More than six million people died due to COVID-19, and 10-15% of infected
individuals suffer from post-covid syndrome. Corticosteroids are widely used in the …

Preparation of polyclonal antibody against phosphatidylethanolamine binding protein 1 recombinant protein and its functional verification in pulmonary hypertension …

Q Li, Y Gu, X Gao, X Guo, C Huang, P Liu, G Hu… - International Journal of …, 2022 - Elsevier
Pulmonary hypertension syndrome (PHS) is a disease that is difficult to overcome for fast-
growing broilers. It causes pulmonary vascular remodeling and ascites in broilers. As a …

[PDF][PDF] COVID-19 and cardiovascular disease: additional risks for patients with chronic kidney disease

L Del Vecchio, O Balafa, E Dounousi… - Nephrology Dialysis …, 2023 - eprints.gla.ac.uk
Millions of people worldwide have chronic kidney disease (CKD). Affected patients are at
high risk for cardiovascular (CV) disease for several reasons. Among various comorbidities …

[PDF][PDF] Efficacy and safety of casirivimab and imdevimab for preventing and treating COVID-19: a systematic review and meta-analysis

Z Cui, H Wang, H Zou, L Li, Y Zhang… - Journal of Thoracic …, 2024 - cdn.amegroups.cn
Background: The ongoing global epidemic of coronavirus disease 2019 (COVID-19) has
created a serious public health problem. The selection of safe and effective therapeutic …